NO20071616L - Benzoksazin- og kinoksalinderivater og anvendelser - Google Patents
Benzoksazin- og kinoksalinderivater og anvendelserInfo
- Publication number
- NO20071616L NO20071616L NO20071616A NO20071616A NO20071616L NO 20071616 L NO20071616 L NO 20071616L NO 20071616 A NO20071616 A NO 20071616A NO 20071616 A NO20071616 A NO 20071616A NO 20071616 L NO20071616 L NO 20071616L
- Authority
- NO
- Norway
- Prior art keywords
- cinoxaline
- benzoxazine
- derivatives
- medicaments
- manufacture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Forbindelse med formel I: eller farmasøytisk akseptabelt salt derav, hvor k, m, n, p, q, X 5 Y, Z, Ar, R1, R2, R3og R4 er som definert her så vel som metoder for fremstillingen av disse, farmasøytiske preparater som inneholder dem og anvendelsen derav for fremstilling av medikament.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61470504P | 2004-09-30 | 2004-09-30 | |
US63060804P | 2004-11-24 | 2004-11-24 | |
PCT/EP2005/010238 WO2006037481A1 (en) | 2004-09-30 | 2005-09-22 | Benzoxazine and quinoxaline derivatives and uses |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20071616L true NO20071616L (no) | 2007-04-25 |
Family
ID=35385358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20071616A NO20071616L (no) | 2004-09-30 | 2007-03-27 | Benzoksazin- og kinoksalinderivater og anvendelser |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1797051B1 (no) |
JP (1) | JP2008514662A (no) |
KR (1) | KR100875041B1 (no) |
AR (1) | AR051115A1 (no) |
AT (1) | ATE477248T1 (no) |
AU (1) | AU2005291541B2 (no) |
BR (1) | BRPI0516754A (no) |
CA (1) | CA2581921A1 (no) |
DE (1) | DE602005022896D1 (no) |
IL (1) | IL182304A0 (no) |
MX (1) | MX2007003911A (no) |
MY (1) | MY139409A (no) |
NO (1) | NO20071616L (no) |
NZ (1) | NZ553848A (no) |
RU (1) | RU2382036C2 (no) |
TW (1) | TW200626567A (no) |
WO (1) | WO2006037481A1 (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4975626B2 (ja) * | 2004-09-30 | 2012-07-11 | エフ.ホフマン−ラ ロシュ アーゲー | 認知障害の処置用の組成物および方法 |
CL2007003044A1 (es) * | 2006-10-24 | 2008-07-04 | Wyeth Corp | Compuestos derivados de benzoxazina; composicion farmaceutica que los comprende; y uso para el tratamiento de un trastorno psicotico, bipolar, depresivo y abuso o dependencia de sustancias entre otros. |
KR20110038180A (ko) * | 2008-09-08 | 2011-04-13 | 에프. 호프만-라 로슈 아게 | 5-치환된 벤즈옥사진 |
CN105541693B (zh) * | 2014-07-08 | 2018-10-16 | 广东东阳光药业有限公司 | 芳杂环类衍生物及其在药物上的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW224941B (no) * | 1989-11-08 | 1994-06-11 | Yamanouchi Pharma Co Ltd | |
JP2002532504A (ja) * | 1998-12-17 | 2002-10-02 | アメリカン・ホーム・プロダクツ・コーポレイション | 5−ht2c作動薬である2,3,4,4a−テトラヒドロ−1h−ピラジノ(1,2−a)キノキサリン−5(6h)−オン誘導体 |
CN1561338A (zh) * | 2001-10-04 | 2005-01-05 | 惠氏公司 | 作为5-羟基色胺-6配体的苯并二氢吡喃衍生物 |
ATE316523T1 (de) * | 2002-05-13 | 2006-02-15 | Hoffmann La Roche | Benzoxazinderivate als 5-ht6-modulatoren und deren verwendungen |
JP4975626B2 (ja) * | 2004-09-30 | 2012-07-11 | エフ.ホフマン−ラ ロシュ アーゲー | 認知障害の処置用の組成物および方法 |
-
2005
- 2005-09-22 BR BRPI0516754-0A patent/BRPI0516754A/pt not_active IP Right Cessation
- 2005-09-22 AU AU2005291541A patent/AU2005291541B2/en not_active Expired - Fee Related
- 2005-09-22 JP JP2007533918A patent/JP2008514662A/ja active Pending
- 2005-09-22 DE DE602005022896T patent/DE602005022896D1/de active Active
- 2005-09-22 WO PCT/EP2005/010238 patent/WO2006037481A1/en active Application Filing
- 2005-09-22 CA CA002581921A patent/CA2581921A1/en not_active Abandoned
- 2005-09-22 MX MX2007003911A patent/MX2007003911A/es active IP Right Grant
- 2005-09-22 EP EP05796666A patent/EP1797051B1/en active Active
- 2005-09-22 KR KR1020077007227A patent/KR100875041B1/ko not_active IP Right Cessation
- 2005-09-22 RU RU2007110479/04A patent/RU2382036C2/ru not_active IP Right Cessation
- 2005-09-22 AT AT05796666T patent/ATE477248T1/de active
- 2005-09-22 NZ NZ553848A patent/NZ553848A/en not_active IP Right Cessation
- 2005-09-27 TW TW094133563A patent/TW200626567A/zh unknown
- 2005-09-27 AR ARP050104050A patent/AR051115A1/es unknown
- 2005-09-28 MY MYPI20054561A patent/MY139409A/en unknown
-
2007
- 2007-03-27 NO NO20071616A patent/NO20071616L/no not_active Application Discontinuation
- 2007-03-29 IL IL182304A patent/IL182304A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2007003911A (es) | 2007-05-21 |
BRPI0516754A (pt) | 2008-09-16 |
TW200626567A (en) | 2006-08-01 |
JP2008514662A (ja) | 2008-05-08 |
DE602005022896D1 (de) | 2010-09-23 |
AU2005291541A1 (en) | 2006-04-13 |
KR20070047844A (ko) | 2007-05-07 |
IL182304A0 (en) | 2007-07-24 |
CA2581921A1 (en) | 2006-04-13 |
NZ553848A (en) | 2010-01-29 |
ATE477248T1 (de) | 2010-08-15 |
AR051115A1 (es) | 2006-12-20 |
RU2382036C2 (ru) | 2010-02-20 |
AU2005291541B2 (en) | 2011-03-10 |
WO2006037481A1 (en) | 2006-04-13 |
KR100875041B1 (ko) | 2008-12-19 |
MY139409A (en) | 2009-09-30 |
EP1797051B1 (en) | 2010-08-11 |
RU2007110479A (ru) | 2008-11-10 |
EP1797051A1 (en) | 2007-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20062491L (no) | Benzoksazinderivter og deres anvendelse | |
NO20091893L (no) | Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav. | |
NO20061839L (no) | Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav | |
NO20052496L (no) | Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter. | |
NO20052074L (no) | Substituerte benzoksazinoner og anvendelser derav. | |
NO20072978L (no) | Nye betuinderivater, preparat derav og anvendelse derav | |
NO20065904L (no) | Terapeutiske forbindelser | |
NO20064166L (no) | Utvalgte CGRP-antagonister, deres fremstilling og deres anvendelse som medikanmenter | |
NO20083434L (no) | Benzamid- og heteroarenderivater | |
NO20072689L (no) | Tetrasykliske indolderivater som antivirale midler | |
JO2353B1 (en) | New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use | |
NO20062713L (no) | 2,6 bisheteroaryl-4-aminopyrimidiner som adenosin reseptor antagonister | |
WO2006005609A3 (de) | Substituierte oxindol-derivate und diese enthaltende arzneimittel | |
NO20052493L (no) | Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger. | |
NO20060147L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
TW200642689A (en) | Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient | |
NO20092033L (no) | Nye forbindelser | |
TW200626598A (en) | Pyrrazolo-pyrimidine derivatives | |
NO20066055L (no) | Pyridinderivater | |
NO20045486L (no) | Nye forbindelser og deres anvendelse | |
NO20075169L (no) | Nye imidazo (1,5-A)pyndindenvater, fremgangsmate for fremstilling og farmasoytiske sammensetninger som inneholder samme. | |
NO20082445L (no) | Neuropeptid-2 reseptor-agonister | |
NO20060146L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
NO20065880L (no) | 3-Amino-l-arylpropylindoler som monoamin-gjenopptagelsesinhibitor | |
NO20054135L (no) | Kipolinon/benzoksazin derivater og anvendelser derav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |